Dissecting the genetic underpinnings of essential tremor

剖析特发性震颤的遗传基础

基本信息

项目摘要

DESCRIPTION (provided by applicant): The long-term goal of this proposal is to identify novel gene mutations underlying essential tremor (ET) to gain insights into its biology and etiology, which are poorly understood. ET is one of the most common neurological diseases in adult life whose prevalence increasing steadily with age. The main motor symptom of ET is an 8- to 12-Hz postural or kinetic tremor of the arms; however, the vast majority of ET patients also develop other motor and non-motor manifestations, frequently causing misdiagnosis. Since most people with ET benefit, or partially benefit, from drug therapy, prompt diagnosis and appropriate treatment are necessary for delaying or preventing the functional disabilities that often make ET patients face financial and other difficulties. In the last few years, exome sequencing (ES) has proved its ability to identify causal alleles for inherited diseases, even in families previously deemed statistically underpowered for positional cloning, and is becoming a fruitful strategy for gene identification in both Mendelian and more complex traits. In this context, because conventional cloning techniques have failed to identify causal genes for ET, we strongly believe that exome sequencing is the most appropriate technique for accelerating gene discovery in essential tremor. Therefore, based on our previous works and own preliminary data that disease genes can readily be identified through the use of ES, the goal of the proposed project is to identify novel gene mutations underlying tremor by applying ES in a clinically and ethnically homogeneous group of patients with ET. The use of genetically homogenous families will reduce both locus and allelic heterogeneity, thus increasing statistical power for gene discovery. To carry out this proposal, we have collected DNA samples from over 100 ET patients, including eight large families, eleven small families, as well as sporadic patients. All proposed ET patients are from the same geographical region in the North of Spain and are subject to an ongoing full clinical trial that includes exhaustive clinical, neurophysiological, neuroimaging, and neuropsychological examinations. All patients developed disease symptoms before the age of 40, suggesting that genetic factors are likely to play a major role in disease development. Based on our preliminary data, we anticipate that novel gene mutations underlying ET will be identified upon completion of the proposed project, thus facilitating the understanding of tremor's overall etiology, prognosis, and treatment. In addition, we strongly believe that the identification of novl tremor genes will greatly contribute to the comprehension of other neurodegenerative diseases such as Parkinson's disease, as having ET increases the risk for developing Parkinson's disease. Lastly, since gene discovery leads directly to model systems, better understanding of pathogenesis, improved diagnostic tests, and novel targets for drug development, the proposed project will enormously contribute to the translation of basic biomedical research into clinical practice, thus benefiting human health and reducing health care cost.
描述(申请人提供):这项建议的长期目标是确定原发性震颤(ET)潜在的新基因突变,以深入了解其生物学和病因学,目前人们对此知之甚少。ET是成人生活中最常见的神经系统疾病之一,其患病率随着年龄的增长呈稳步上升趋势。ET的主要运动症状是手臂8-12赫兹的姿势或运动性震颤;然而,绝大多数ET患者还会出现其他运动和非运动表现,经常导致误诊。由于大多数ET患者受益于或部分受益于药物治疗,因此及时诊断和适当治疗对于延缓或预防经常使ET患者面临经济和其他困难的功能障碍是必要的。在过去的几年里,外显子组测序(ES)已经证明了它能够识别遗传病的因果等位基因,即使在以前被认为是位置克隆能力不足的家庭中也是如此,并且正在成为一种卓有成效的孟德尔和更复杂性状的基因鉴定策略。在这种背景下,由于传统的克隆技术无法识别ET的致病基因,我们强烈认为外显子组测序是加速特发性震颤基因发现的最合适的技术。因此,基于我们以前的工作和自己的初步数据,通过使用ES可以很容易地识别疾病基因,拟议的项目的目标是通过在临床和种族相同的ET患者组中应用ES来识别潜在震颤的新的基因突变。基因同源家系的使用将减少基因座和等位基因的异质性,从而增加基因发现的统计能力。为了实现这一建议,我们收集了100多名ET患者的DNA样本,其中包括8个大家庭,11个小家庭,以及散发性患者。所有建议的ET患者 都来自西班牙北部的同一地理区域,正在接受全面的临床试验,包括详尽的临床、神经生理学、神经成像和神经心理学检查。所有患者在40岁之前都出现了疾病症状,这表明遗传因素可能在疾病发展中发挥主要作用。根据我们的初步数据,我们预计在拟议的项目完成后,将识别出与ET相关的新的基因突变,从而有助于了解震颤的总体病因、预后和治疗。此外,我们坚信,识别新的震颤基因将极大地有助于理解其他神经退行性疾病,如帕金森病,因为ET增加了发生帕金森病的风险。最后,由于基因发现直接导致模型系统,更好地了解发病机制,改进的诊断测试,以及药物开发的新靶点,拟议的项目将极大地促进基础生物医学研究转化为临床实践,从而造福人类健康,降低医疗成本。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Coro Paisan-Ruiz其他文献

Coro Paisan-Ruiz的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Coro Paisan-Ruiz', 18)}}的其他基金

Elucidating and understanding the genetic basis of movement disorders
阐明和理解运动障碍的遗传基础
  • 批准号:
    8841023
  • 财政年份:
    2013
  • 资助金额:
    $ 25.43万
  • 项目类别:
Dissecting the genetic underpinnings of essential tremor
剖析特发性震颤的遗传基础
  • 批准号:
    8636504
  • 财政年份:
    2013
  • 资助金额:
    $ 25.43万
  • 项目类别:
Elucidating and understanding the genetic basis of movement disorders
阐明和理解运动障碍的遗传基础
  • 批准号:
    9038786
  • 财政年份:
    2013
  • 资助金额:
    $ 25.43万
  • 项目类别:
Elucidating and understanding the genetic basis of movement disorders
阐明和理解运动障碍的遗传基础
  • 批准号:
    8627217
  • 财政年份:
    2013
  • 资助金额:
    $ 25.43万
  • 项目类别:
Elucidating and understanding the genetic basis of movement disorders
阐明和理解运动障碍的遗传基础
  • 批准号:
    8500950
  • 财政年份:
    2013
  • 资助金额:
    $ 25.43万
  • 项目类别:

相似海外基金

Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
  • 批准号:
    495182
  • 财政年份:
    2023
  • 资助金额:
    $ 25.43万
  • 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
  • 批准号:
    2601817
  • 财政年份:
    2021
  • 资助金额:
    $ 25.43万
  • 项目类别:
    Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
  • 批准号:
    2029039
  • 财政年份:
    2020
  • 资助金额:
    $ 25.43万
  • 项目类别:
    Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
  • 批准号:
    9888417
  • 财政年份:
    2019
  • 资助金额:
    $ 25.43万
  • 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
  • 批准号:
    17K11318
  • 财政年份:
    2017
  • 资助金额:
    $ 25.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    9320090
  • 财政年份:
    2017
  • 资助金额:
    $ 25.43万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    10166936
  • 财政年份:
    2017
  • 资助金额:
    $ 25.43万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    9761593
  • 财政年份:
    2017
  • 资助金额:
    $ 25.43万
  • 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
  • 批准号:
    BB/M50306X/1
  • 财政年份:
    2014
  • 资助金额:
    $ 25.43万
  • 项目类别:
    Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
  • 批准号:
    288272
  • 财政年份:
    2013
  • 资助金额:
    $ 25.43万
  • 项目类别:
    Miscellaneous Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了